Ocugen plans to seek full approval for Covaxin in US

Ocugen plans to seek full approval for Covaxin in US

Source: 
Pharmaceutical Business Review
snippet: 

Ocugen has announced plans to seek full approval from the US Food and Drug Administration (FDA) for Covid-19 vaccine candidate, Covaxin.